metricas
covid
Annals of Hepatology Hepatoblastoma
Journal Information
Vol. 4. Issue 2.
Pages 131 (April - June 2005)
Vol. 4. Issue 2.
Pages 131 (April - June 2005)
Open Access
Hepatoblastoma
Visits
1474
Raùl Pichardo-Bahena1, Nahum Méndez-Sánchez1,
Corresponding author
nmendez@medicasur.org.mx

Address for correspondence:
1 Department of Pathology and Liver Unit. Medica Sur Clinic & Foundation. Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

A 12-month-old male with diagnosis of hepatoblastoma (Figure 1).

Figure 1.

The neoplasm has a solid and nodular growth pattern, divided by thin, fibrous, connective tissue septum.

Hepatoblastoma is the most common malignant tumor of the liver in the pediatric population, affecting mostly young boys age < 3 years and accounting for 75% of primary liver tumors in childhood. Diagnosis is usually at a late stage. Nevertheless, the introduction of chemotherapy with cisplatin and doxorubicin has changed the treatment success of hepatoblastoma substantially, and despite a large tumor mass at presentation, a combined surgical and chemotherapeutic approach has yielded a 5-year survival rateof approximately 80%.

References
[1.]
Kew M.C..
Tumors of the liver.
Hepatology. A textbook in liver disease, Third, pp. 1513-1564
[2.]
Hertl M., Cosimi A.B..
Liver transplantation for malignancy.
Oncologist, 10 (2005), pp. 269-281
Copyright © 2005. Fundación Clínica Médica Sur, A.C.
Download PDF
Article options
Tools